CVM will be taken over at $20.00 in 2013, enjoy the ride.
Let it be written,
Dr. Tony Montello.
Sentiment: Strong Buy
Doc, take two apirin and call me in the morning..
I believe that you've forgotten that it is not possible for companies to publish data on pivotal trials in progress unless they have pre-specified an interim look in the trial protocol.
Not only has CVM not included an interim look in its frce of a PhIII, it hasn't even come close yet to enrolling anywhere near half of the planned number of subjects.
Of course, a blatant POS scumball such as you cares nothing about facts. I'm just glad you're stuck in this POS scam. CVM, because you're going to lose everything! LOL!!!
how do you know how many subject are enrolled when the company does not report it?